RE:RE:RE:RE:I can't wait@InvertedHammer clearly you are a tool. Where did I say large companies only sign big dollar contracts?
I said I wouldnt expect it to be a low dollar figure based on its a supply contract that doesnt mention a "pilot project" with a major US pharma company associated with a market leading ophthalmology product indicated for a variety of ophthalmic complications including diabetes.
Clearly the potential size of that demographic in the US alone is a very large number client base and therefore would EXPECT a large revenue associated with that.
Never even implied that large companies only sign big dollar contracts but I do know for a fact large companies do only sign contracts with respectable and established companies thus the validation to CARA's proficiency and potential.
If there wasnt any benefit to this major pharma companies direction they wouldnt be interested. That is irrefutable.